Kala Pharmaceuticals
IPO
- Headquarters
- Waltham, Massachusetts
- Founded
- 2009
- Business Model
- B2B
- Website
- kalapharmaceuticals.com
- Total Funding
- $79.5M
- Last Round
- $68.0M Venture RoundApr 2016
About
Clinical-stage biopharma developing topical nanoparticle therapies for eye diseases, including treatments for dry eye and ocular inflammation.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account